Cargando…
Prediction of Ischemic Events after Percutaneous Coronary Intervention: Thrombelastography Profiles and Factor XIIIa Activity
Background High plasma fibrin clot strength (MA) measured by thrombelastography (TEG) is associated with increased risk of cardiac events after percutaneous coronary interventions (PCIs). Factor XIIIa (FXIIIa) cross-links soluble fibrin, shortens clot formation time (TEG-K), and increases final clo...
Autores principales: | Kreutz, Rolf P., Schmeisser, Glen, Schaffter, Andrea, Kanuri, Sri, Owens, Janelle, Maatman, Benjamin, Sinha, Anjan, von der Lohe, Elisabeth, Breall, Jeffrey A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419750/ https://www.ncbi.nlm.nih.gov/pubmed/30882064 http://dx.doi.org/10.1055/s-0038-1645876 |
Ejemplares similares
-
Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography
por: Maatman, Benjamin T., et al.
Publicado: (2018) -
Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention
por: Kreutz, Rolf P, et al.
Publicado: (2016) -
Thrombelastography and sepsis
por: Puana, Rudolph, et al.
Publicado: (2007) -
Pharmacogenomics of Novel Direct Oral Anticoagulants: Newly Identified Genes and Genetic Variants
por: Kanuri, Sri H., et al.
Publicado: (2019) -
Ethacrynic acid is an inhibitor of human factor XIIIa
por: Kar, Srabani, et al.
Publicado: (2022)